Top Suppliers:I want be here




206361-99-1

206361-99-1 structure
206361-99-1 structure
  • Name: Darunavir
  • Chemical Name: darunavir
  • CAS Number: 206361-99-1
  • Molecular Formula: C27H37N3O7S
  • Molecular Weight: 547.664
  • Catalog: API Antibiotics Other antibiotics
  • Create Date: 2018-09-21 20:53:50
  • Modify Date: 2025-08-24 18:59:13
  • Darunavir(TMC114) is an HIV protease inhibitor.IC50 Value: Target: HIV ProteaseDarunavir HIV-1 antiviral structurally is similar to amprenavir and it is second generation HIV-1-protease inhibitor. Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naive and treatment-experienced adults and adolescents.

Name darunavir
Synonyms (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](isobutyl)amino}-3-hydroxy-1-phenyl-2-butanyl]carbamate
Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester
Darunavir
TMC-114
(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](isobutyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate
Description Darunavir(TMC114) is an HIV protease inhibitor.IC50 Value: Target: HIV ProteaseDarunavir HIV-1 antiviral structurally is similar to amprenavir and it is second generation HIV-1-protease inhibitor. Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naive and treatment-experienced adults and adolescents.
Related Catalog
Density 1.3±0.1 g/cm3
Melting Point 74-76ºC
Molecular Formula C27H37N3O7S
Molecular Weight 547.664
Exact Mass 547.235229
PSA 148.80000
LogP 3.94
Index of Refraction 1.620
Storage condition -20°C Freezer
Hazard Codes Xi
RIDADR NONH for all modes of transport
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.